In addition, phosphorylation levels of Protein Kinase C (PKC) isoforms, a class of proteins previously linked to resistance to anti-RTK targeted agents [41, 42] and EMT in cancer [43, 44], were also reduced in super-sensitive MCPs (Fig. 6C). This evidence concerns the gene PRRT2 and cancer.